| Impairment ADL | Impairment IADL | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | ROC AUC* (95% CI), significance (p) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | ROC AUC* (95% CI), significance (p) | |
Probable sarcopenia | 63.5 | 47.8 | 54.4 | 56.7 | 0.554 (0.499–0.610), 0.6 | 83.6 | 46.4 | 21.5 | 94.2 | 0.650 (0.582–0.718) < 0.001 |
Confirmed sarcopenia/W | 22.2 | 84.9 | 59.2 | 52.4 | 0.535 (0.479–0.591) 0.22 | 36 | 84.4 | 29 | 88.3 | 0.603 (0.520–0.685) 0.01 |
Confirmed sarcopenia/BMI | 35 | 78.1 | 61.2 | 54.8 | 0.565 (0.509–0.621), 0.02 | 57.4 | 76.7 | 30.2 | 91.1 | 0.670 (0.592–0.748) < 0.001 |
Confirmed sarcopenia/H2 | 0 | 99.5 | 0 | 50 | 0.498 (0.441–0.554) 0.932 | 0 | 99.7 | 0 | 85.1 | 0.499 (0.420–0.577) > 0.5 |
Sarcopenic obesity/W&BMI** | 7.4 | 93.7 | 53.6 | 50.5 | 0.505 (0.449–0.561) 0.86 | 11.5 | 94 | 25 | 85.8 | 0.527 (0.446–0.608) 0.5 |
Obesity | 41.4 | 68.3 | 56.4 | 54.1 | 0.548 (0.493–0.604) 0.09 | 49.2 | 65.7 | 20.1 | 88 | 0.574 (0.495–0.654) 0.06 |